Dr Gabriela Khoury
gabrielakhoury.bsky.social
Dr Gabriela Khoury
@gabrielakhoury.bsky.social
Antiviral Immunity Theme Leader at Burnet Institute Melbourne. Exec CI PROPHECY COVID vaccine MRFF. LOC AVS2024. We study vaccine and viral immunity in vulnerable populations. Plus the impact of viruses on our health.
Pinned
A whole new world over here @bluesky! I am based at the Burnet Institute and my team study the impact of viral infections on health, immune responses to infections and vaccines in variety of vulnerable populations. #WomenInSTEM
I say this with teary eyes. Thank you Lily Schubert & Tracey Collins for bravely sharing your personal #MECFS stories 🙏 You inspire myself & the team to keep trying to find answers in the lab. We hope our work will lead to therapies & better tests for earlier diagnosis @emergeaustralia.bsky.social
The first speaker is Lily Schubert. Lily is an Emerge Australia ambassador who lives with ME/CFS, POTS and other related conditions, and was bedbound for six years.
October 30, 2025 at 3:01 AM
In lab news this month! Congratulations to Maddison Cali, our honours student who was awarded the Best 10min talk at @burnetinstitute.bsky.social student symposium this month! 👏👏👏 Maddison studies post-acute infection syndromes including POTS and Long COVID. (📸Back row, on right end).
September 25, 2025 at 2:11 AM
Reposted by Dr Gabriela Khoury
📝 Working on a manuscript? Not sure on how to navigate the submission process?

Join our next workshop “Manuscript Mastery” for all the tips and tricks on how to prepare your work for publication!

🕰️ Wed 10th Sept 10am - 12pm

Register by 5pm Friday 5th September
bit.ly/45gWCst
August 14, 2025 at 5:56 AM
Excited to share our 1st paper from our collaboration with @ianjohnwoolley.bsky.social & Spleen Australia is published! We describe predictors of VZV& shingles vaccine uptake in asplenia. Also a good reminder to all eligible adults to get their shingles vaccine! www.sciencedirect.com/science/arti...
Varicella zoster virus reactivation episodes and vaccination uptake in Spleen Australia registrants
The Australian National Immunisation Program recently made the recombinant zoster vaccine (RZV), Shingrix, available to First Nations people (Aborigin…
www.sciencedirect.com
June 25, 2025 at 10:34 PM
Proud supervisor moment this afternoon! Our honours student, Maddison, did a great job presenting their project on post-acute infection syndromes. There was heaps of interest and Maddison fielded many questions. 👏 Watch this space for updates on this exciting project! 🧪🥼🧫
June 12, 2025 at 7:03 AM
Are you a spectral flow cytometry guru? Join my team @burnetinstitute.bsky.social in Melbourne, where you will contribute to vaccine immunological response studies in immunocompromised and vulnerable people.
www.seek.com.au/job/84837146...
Research Assistant - Flow Cytometry Job in Melbourne VIC - SEEK
Join a world-renowned research institute and work within our Antiviral Immunity Laboratory team!
www.seek.com.au
June 11, 2025 at 8:32 AM
I met Plum Stone @plumskyjam.bsky.social the founder of @saferairproject.bsky.social in Canberra last year. Plum is a passionate advocate for clean indoor air for all and lives with #LongCovid. Tune into @emergeaustralia.bsky.social podcast where she talks with CEO, Anne Wilson.
Specialist in cancer policy, Plum Stone, highlights health risks of poor indoor air quality through The Safer Air Project. she started following her long COVID battle. Check out her insights at vist.ly/3mxb88j.
March 14, 2025 at 10:06 PM
It is #LongCOVID Awareness Day. At least 10% of people will experience symptoms for many months, even years after COVID. These can be debilitating & impact everyday things we all take for granted. We hear you! Our lab is studying the causes behind LC. We hope to find better diagnostics & treatments.
March 14, 2025 at 9:57 PM
Go team Burnet! 👏 It is amazing to think that a Hep C vaccine could be on the horizon. Great work by Dr Joey McGregor, Prof Heidi Drummer, Dr Andy Poumbourios the team. #lorneiandi @burnetinstitute.bsky.social
Fantastic talk by Dr Joey McGregor from @burnetinstitute.bsky.social who presented exciting work on novel mRNA vaccine targets for Hepatitis C. #lorneiandi
February 19, 2025 at 6:38 AM
Reposted by Dr Gabriela Khoury
November 29, 2024 at 12:24 AM
📚 For those of you out there interested in the role of SARS-COV-2 reservoirs and persistence in Long COVID. Check out our earlier perspective in @mja.com.au it came out late 2024 but certainly relevant today! #LongCOVID
onlinelibrary.wiley.com/doi/10.5694/...
Towards a cure for long COVID: the strengthening case for persistently replicating SARS‐CoV‐2 as a driver of post‐acute sequelae of COVID‐19
Click on the article title to read more.
onlinelibrary.wiley.com
February 13, 2025 at 6:23 AM
Reposted by Dr Gabriela Khoury
1/ Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients

In a new report, global experts outline key considerations to address persistent SARS-CoV-2; provide a
roadmap to test critical new long COVID therapies

polybio.org/cutting-edge...
Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients - PolyBio Research Foundation
In a new report, global experts outline key considerations to address persistent SARS-CoV-2; provide a roadmap to test critical new long...
polybio.org
February 11, 2025 at 2:27 PM
Reposted by Dr Gabriela Khoury
Long-COVID incidence proportion in adults and children between 2020 and 2024

✅ Just Accepted
#IDSky
Long-COVID incidence proportion in adults and children between 2020 and 2024
Incidence estimates of post-acute sequelae of SARS-CoV-2 infection, also known as long-COVID, have varied across studies and changed over time.
buff.ly
February 8, 2025 at 7:58 PM
🐳 Join us in sunny Lorne, Australia next month, 19-21 Feb, for the @theviin.bsky.social Infection and Immunity Conference. 🪼 Absolutely great line-up this year! In person (sea-side🐚) and virtual registration options available too. Don't miss out- www.lorneinfectionimmunity.org/registration
January 29, 2025 at 5:17 AM

Our other focus is studying vaccine responses in vulnerable people. In July we published our first study on serological responses & clinical outcomes of 3‐dose #COVID19 vaccine schedule in kidney #transplant recipients & people on #dialysis. doi.org/10.1002/cti2... More on these groups in 2025! 1/2
<em>Clinical & Translational Immunology</em> | ASI Journal | Wiley Online Library
In this study, we found that serological responses to COVID-19 vaccines in kidney transplant recipients lag behind people receiving dialysis by approximately one dose. Predictors of poor responses we...
doi.org
December 9, 2024 at 8:06 AM
Reposted by Dr Gabriela Khoury
Very beneficial discussions during #AVS12 panel on Indigenous virology including how the Nagoya Protocol relates to our work - lots to learn but here is some basic information specific to Australia: www.dcceew.gov.au/science-rese...
www.dcceew.gov.au
December 5, 2024 at 12:27 AM
Next up at #AVS12 is the Indigenous Virology session. Looking forward to hearing from the panel members - Natalie Netzlar, Allison Imrie, Trevor Lithgow &
Lloyd Dolan. To get insights on how AVS and research in general can improve representation of first nations people in the field of Virology.
December 4, 2024 at 11:21 PM
Reposted by Dr Gabriela Khoury
Did you know there are viruses big enough to have their own viruses? Chantel Abergel went back to the land of dinosaurs in the permafrost to discover many weird and wonderful giant viruses 🤯 #AVS12 #virology @ausvirologysoc.bsky.social
December 3, 2024 at 7:01 AM
Using oncolytic viruses to fight transmissible facial tumours in Tassie Devils is such a cool approach!💥 Anjali Gowripalam's research has focused on selecting the right vector to 'vaccinate' devils. Does using poxvirus vector system mean life long Immunity? Watch this space! #AVS12
Next up is Anjali Gowripalan
Who is Using oncolytic viruses to save Tasmanian devils from transmissible facial tumours. A crushing disease for such a charismatic species. #AVS12
December 3, 2024 at 11:58 PM
Really enjoyed this #AVS12 talk by Branka Grubor-Bauk. Looking forward to seeing more on the development of this vaccine against ZIKV which has such devastating effects.
Despite the devastating #Zika virus epidemic (2015-2016), no ZIKV vaccine is available. Finalising our mRNA/Vaccine session is Branka Grubor-Bauk (University of Adelaide) who is presenting the development of a Multivalent T cell vaccine against Zika virus. #AVS12
December 3, 2024 at 11:47 PM
Reposted by Dr Gabriela Khoury
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
There are already many articles for which there is more attention on Bluesky than on other comparable micro-blogging sites, meaning the academic community and the general public have clearly adopted Bluesky as one of its core places to disseminate and discuss new research.

A Place of Joy.
December 3, 2024 at 2:10 PM
Reposted by Dr Gabriela Khoury
We are lucky that the Rob Webster oration this year is Chantal Abergel who has travelled from the CNRS-AMU, Marseille where she is the director of Information Génomique et Structurale. Chantal is presenting 20 years of research on giant viruses. #AVS12
December 3, 2024 at 6:11 AM
Fabulous turn out at the #AVS12 career panel discussion. The crowd had fantastic questions! Our panel had plenty of wisdom to share. Thank you to our engaging panelists- @profpaulyoung.bsky.social Stephanie Gras, Fassili Coulibaly, Stacey Lynch, & Byron Shue. @ausvirologysoc.bsky.social
December 2, 2024 at 10:29 AM
This week I'm posting live from #AVS12. Starting off the conference with our special ECR sessions that I have been fortunate to co-host with 2 great ECRs @ebony-monson.bsky.social and Robson Kriiger Loterio. @ausvirologysoc.bsky.social
December 2, 2024 at 10:08 AM